Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMIRE-CD phase III study of Cx601 for complex perianal fistulising Crohn's disease
NL-OMON41535Phase 3Active, not recruiting
- Sponsor
- TiGenix
- Start
- Sep 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3 trial of darvadstrocel, sponsored by TiGenix. Started Sep 2012; status: active, not recruiting.
02
Drugs
darvadstrocel
Beyond the preview
Go deeper on NL-OMON41535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41535.